Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
about
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.Late effects of blood and marrow transplantation.Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study.Herpes zoster incidence in a multicenter cohort of solid organ transplant recipientsHerpes zoster: diagnostic, therapeutic, and preventive approaches.Zeroing in on zoster: A tale of many disorders produced by one virusDisseminated herpes zoster infection initially presenting with abdominal pain in patients with lymphoma undergoing conventional chemotherapy: A report of three cases.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation.Predicting risk factors for varicella zoster virus infection and postherpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis.Herpes zoster after autologous hematopoietic stem cell transplantation.In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation.Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation.Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis.Immunity and the burden of herpes zoster.Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia.Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.Eczema herpeticum with herpetic folliculitis after bone marrow transplant under prophylactic acyclovir: are patients with underlying dermatologic disorders at higher risk?Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation.A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.
P2860
Q30235260-2C60AB6F-9BF3-4AE9-B388-7751C6AB3EFEQ33574136-0E33918B-EEDA-441C-8CAD-E069AC1DABDDQ33621313-606AC20C-AC75-4972-8888-378B984117F2Q34293248-0DAD3775-E244-4C8F-A8B3-2AF7985B53B4Q34376752-EF9B814E-FB79-466B-A818-BF4224BAE26AQ36236794-9DB67259-9F50-49E7-B9B2-613B79748D43Q37108449-90EABBEB-EAF8-4743-BF89-08A9C98F19E5Q37150434-B4AF72AC-42FE-4093-9493-E8BE28D66D92Q37182608-2295AE6F-5576-4AFC-8969-E7710B300636Q37697290-2F79E2B6-72F3-46F4-AA23-242FBB78A759Q37809492-7EE1DAFC-137E-49F7-B1ED-86342C43DEF3Q37984818-E70F1163-FAB0-4735-A466-70266205F8D3Q39023136-6A94AF2A-EEB8-4B77-85E2-2F2BB31A90D3Q39173692-5FCEAC36-08B7-457D-BA1F-0771804D8947Q39459351-EA7E7B87-CE1F-4177-A7FA-BE200AA7EA8AQ40922474-CFF108A2-425B-4C67-859D-2EBAA37079BAQ41535668-E13BC877-C7EF-40A2-AA35-5001EAC7875CQ41695426-6F5AB41B-CC92-4918-A261-3DAA4731A72AQ42197783-1BDB1550-63BC-4EE6-BBD6-58A97B18F7D1Q42242684-764849FB-BFEA-47A3-A7A3-B42E624ED8F8Q42280732-D9CB85D5-63B2-4A33-94D3-5710B62FB5F4Q43014781-C3BD2923-BD4C-4BD6-ABF2-800D6B045B8FQ43246066-536DFC37-9AE9-470B-A7AC-23C016886396Q44015599-824B66DF-C50D-40F0-98FB-7D6A9FD73F80Q50908224-52C4B66E-E82E-4D8B-93B9-F56F7900A7C1Q51348958-9F32EAED-494B-4026-AFAF-7C1FBB7DFE84Q53327420-E24B6BB0-BC1B-41D9-B9A3-3DC182329754
P2860
Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Long-term ultra-low-dose acycl ...... tic stem cell transplantation.
@en
Long-term ultra-low-dose acycl ...... tic stem cell transplantation.
@nl
type
label
Long-term ultra-low-dose acycl ...... tic stem cell transplantation.
@en
Long-term ultra-low-dose acycl ...... tic stem cell transplantation.
@nl
prefLabel
Long-term ultra-low-dose acycl ...... tic stem cell transplantation.
@en
Long-term ultra-low-dose acycl ...... tic stem cell transplantation.
@nl
P2093
P2860
P356
P1476
Long-term ultra-low-dose acycl ...... tic stem cell transplantation.
@en
P2093
Akihito Shinohara
Akira Hangaishi
Hideki Nakasone
Hiroyuki Sato
Koji Izutsu
Kumi Oshima
Mineo Kurokawa
Noriko Hosoya
Shigeru Chiba
Shinichi Kako
P2860
P304
P356
10.1002/AJH.21152
P577
2008-06-01T00:00:00Z